KOHI, IVI exchange MOU on global health capacity-building and education
- Parties agree to strengthen cooperation in global education in health and healthcare, vaccines:
- To develop and operate programs for nurturing global human resources in health and healthcare
- To expand development of global human resources in infectious diseases and vaccines
- To co-host and support IVI’s International Vaccinology Course, international fora and symposia
June 29, 2017, Seoul, Korea - The Korea Human Resource Development Institute for Health and Welfare (KOHI, President: CHOI Young Hyun), and the International Vaccine Institute (IVI) exchanged an MOU to strengthen cooperation in global education in the public health and healthcare fields at IVI headquarters in Seoul on June 29. The MOU was exchanged with the aim to increase human capital in health, healthcare and vaccines, and to promote career development of health professionals through educational programs and R&D cooperation between the two organizations.
Key areas of cooperation include:
- Global human resource development programs for public health and biomedical fields;
- Expansion of development of global and domestic human resources and professionals in infectious diseases and vaccines; and
- Co-hosting and support of IVI’s International Vaccinology Course and other international fora or symposia.
KOHI is an agency under the Korean Ministry of Health & Welfare (MOHW), which has been expanding cooperation, joint research, and support to build human capital in the health and healthcare fields. KOHI plans to jointly host and support IVI’s International Vaccinology Course, a weeklong course for public health and vaccine professionals, as well as co-organize international fora and symposia. The 17th International Vaccinology Course will take place on September 4-8, 2017 at the IVI headquarters.
“We are pleased to support training initiatives in public health and vaccines in collaboration with KOHI,” IVI Director General Dr. Jerome Kim said. “IVI is committed to expanding exchanges and cooperation with public and private sector organizations in Korea and around the world to synergize not only vaccine R&D but also capacity building and human resources development.”
The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines against enteric and diarrheal infections, Japanese encephalitis, MERS-CoV, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit http://www.ivi.int.
Tae Kyung Byun
Senior Manager of Korean Communications
Tel: +82 -2-881-1159